Results 21 to 30 of about 642,460 (243)

Predictors for low coverage of uptake of second dose of measles vaccine among children in sub-Saharan Africa, 2023: a systematic review and meta-analysis [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Background Measles became a public health important disease in sub-Saharan Africa. World Health Organization recommended measles-containing vaccine dose 2 (MCV2) through routine service delivery.
Tamirat Melis   +5 more
doaj   +2 more sources

Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection

open access: yesnpj Vaccines, 2017
Measles: The efficacy of needle-free vaccine delivery Research shows that measles aerosol vaccination is effective when the vaccine is delivered to the lower respiratory tract.
Rik L. de Swart   +12 more
doaj   +2 more sources

An assessment of measles vaccine effectiveness, Australia, 2006-2012

open access: yesWestern Pacific Surveillance and Response, 2015
Objective: Vaccine effectiveness analysis serves as a critical evaluation for immunization programmes and vaccination coverage. It also contributes to maintaining public confidence with the vaccine providers.
Alexis Pillsbury, Helen Quinn
doaj   +2 more sources

Measles Vaccines [PDF]

open access: bronzeProceedings of the Royal Society of Medicine, 1974
A. J. Beale
openaire   +3 more sources

Cross-sectional Survey on Parental Perception and Attitude on Measles Vaccine: Low Hospital Measles Case Presentation in Rural Area in Enugu, Nigeria [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: The incidence of measles has spiked in recent times despite the efforts to its eradication using a highly effective measles vaccine. Vaccine coverage and underreporting of cases are the major challenges to this effort.
Chukwuemeka Chijoke Nwangwu   +2 more
doaj   +1 more source

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine

open access: yesShanghai yufang yixue, 2022
Measles is an acute respiratory infectious disease caused by the measles virus. It is highly infectious and easy to occur in children. It causes many serious complications such as tracheitis, otitis media and pneumonia. Since the promotion of the measles
SHEN Jinhua   +4 more
doaj   +1 more source

Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Nigeria has one of the highest measles burdens in the world. While measles-containing vaccine is proven to be effective in reducing measles cases, empirical studies on the correlation between measles incidence and measles vaccine coverage in Nigeria has ...
Ryoko Sato   +3 more
doaj   +1 more source

Measles Rash Identification Using Residual Deep Convolutional Neural Network [PDF]

open access: yes2021 IEEE International Conference on Big Data (Big Data), 2020
Measles is extremely contagious and is one of the leading causes of vaccine-preventable illness and death in developing countries, claiming more than 100,000 lives each year. Measles was declared eliminated in the US in 2000 due to decades of successful vaccination for the measles.
arxiv   +1 more source

Impact of network assortativity on epidemic and vaccination behaviour [PDF]

open access: yeschaos, solitons & fractals,140:110143, 2020, 2020
The resurgence of measles is largely attributed to the decline in vaccine adoption and the increase in mobility. Although the vaccine for measles is readily available and highly successful, its current adoption is not adequate to prevent epidemics. Vaccine adoption is directly affected by individual vaccination decisions, and has a complex interplay ...
arxiv   +1 more source

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

open access: yesMolecular Therapy: Oncolytics, 2016
To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy